SLU-PP 332 5 mg – 10 Vials

SLU-PP-332 is a cutting-edge synthetic peptide that acts as a selective ERRα/γ (Estrogen-Related Receptor alpha and gamma) agonist, representing a novel approach to metabolic enhancement and endurance improvement. Developed by researchers at the Scripps Research Institute and Washington University School of Medicine, this compound mimics the benefits of exercise at the molecular level without requiring physical activity – often referred to as an “exercise mimetic.” In groundbreaking research published in 2024, SLU-PP-332 was shown to dramatically increase endurance capacity (up to 70% in some studies), enhance fat oxidation, improve insulin sensitivity, and reduce obesity in animal models. The peptide works by activating metabolic pathways normally triggered by endurance training, increasing mitochondrial function, and promoting fat burning. While still in preclinical stages, it represents a promising future therapy for obesity, metabolic syndrome, and conditions where exercise is difficult or impossible.